Faraz Masood, MD
Hospitalist · South Chesterfield, VANPI 1609071661
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $753 and has fallen 83.1% since, to $127 in 2025. Among hospitalist clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 93 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$372
- AbbVie$317
- Edwards Lifesciences$107
- Novo Nordisk$105
- AstraZeneca$100
- Lilly USA, LLC$97
- plus $522 from 15 others
What the payments were for
- Food & beverage$1,619100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,619 in reported general payments places this provider in the 95th percentile of 539 hospitalist providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 26 | $14,111 |
| Humalog Kwikpen U-100Insulin Lispro | 20 | $1,532 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $823 |
| Gabapentin | 23 | $527 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $368 |
| Hydrocortisone | 12 | $348 |
| Atorvastatin Calcium | 26 | $293 |
| Ipratropium-AlbuterolIpratropium/Albuterol Sulfate | 11 | $268 |
| Mirtazapine | 12 | $231 |
| Omeprazole | 13 | $228 |
| Tamsulosin Hcl | 18 | $223 |
| Metoprolol Succinate | 15 | $218 |
| Amlodipine Besylate | 30 | $210 |
| Sertraline Hcl | 12 | $199 |
| Duloxetine Hcl | 13 | $180 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in South Chesterfield
- Yuri MaricichCharlottesville$212K
- Dennis NguyenSpringfield$8K
- Muhammad AfridiWinchester$7K
- Lana WahidRoanoke$6K
- Emily KinseyRichmond$5K
- Mohammed AmerNewport News$5K
- Jill CouchNorton$3K
- John MelsonCharlottesville$2K
- Lisa HuangChesapeake$2K
- Roya QaemiFredericksburg$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.